These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20156956)

  • 1. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project.
    McHugh GS; Butcher I; Steyerberg EW; Marmarou A; Lu J; Lingsma HF; Weir J; Maas AI; Murray GD
    Clin Trials; 2010 Feb; 7(1):44-57. PubMed ID: 20156956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to increase statistical power in TBI trials: insights from the IMPACT study.
    Maas AI; Lingsma HF;
    Acta Neurochir Suppl; 2008; 101():119-24. PubMed ID: 18642645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials.
    Ilodigwe D; Murray GD; Kassell NF; Torner J; Kerr RS; Molyneux AJ; Macdonald RL
    J Neurosurg; 2013 Jan; 118(1):3-12. PubMed ID: 23039145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research?
    Price M; Hertzberg V; Wright DW
    Clin Trials; 2013; 10(6):924-34. PubMed ID: 23027647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.
    Yeatts SD; Martin RH; Meurer W; Silbergleit R; Rockswold GL; Barsan WG; Korley FK; Wright DW; Gajewski BJ
    J Neurotrauma; 2020 Dec; 37(24):2674-2679. PubMed ID: 32664792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of outcome measures and analysis methods for traumatic brain injury trials.
    Alali AS; Vavrek D; Barber J; Dikmen S; Nathens AB; Temkin NR
    J Neurotrauma; 2015 Apr; 32(8):581-9. PubMed ID: 25317951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?
    Roozenbeek B; Maas AI; Lingsma HF; Butcher I; Lu J; Marmarou A; McHugh GS; Weir J; Murray GD; Steyerberg EW;
    Crit Care Med; 2009 Oct; 37(10):2683-90. PubMed ID: 19885979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury.
    Maas AI; Steyerberg EW; Marmarou A; McHugh GS; Lingsma HF; Butcher I; Lu J; Weir J; Roozenbeek B; Murray GD
    Neurotherapeutics; 2010 Jan; 7(1):127-34. PubMed ID: 20129504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.
    Roozenbeek B; Lingsma HF; Perel P; Edwards P; Roberts I; Murray GD; Maas AI; Steyerberg EW; ;
    Crit Care; 2011; 15(3):R127. PubMed ID: 21586148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.
    Peterson RL; Vock DM; Powers JH; Emery S; Cruz EF; Hunsberger S; Jain MK; Pett S; Neaton JD;
    Clin Trials; 2017 Jun; 14(3):264-276. PubMed ID: 28397569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?
    Weir J; Steyerberg EW; Butcher I; Lu J; Lingsma HF; McHugh GS; Roozenbeek B; Maas AI; Murray GD
    J Neurotrauma; 2012 Jan; 29(1):53-8. PubMed ID: 22026476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ordinal outcome analysis improves the detection of between-hospital differences in outcome.
    Ceyisakar IE; van Leeuwen N; Dippel DWJ; Steyerberg EW; Lingsma HF
    BMC Med Res Methodol; 2021 Jan; 21(1):4. PubMed ID: 33407167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment for binary, ordinal, and time-to-event outcomes".
    Proschan MA
    Biometrics; 2021 Dec; 77(4):1482-1484. PubMed ID: 34105763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.
    Benkeser D; Díaz I; Luedtke A; Segal J; Scharfstein D; Rosenblum M
    Biometrics; 2021 Dec; 77(4):1467-1481. PubMed ID: 32978962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes.
    Li B; Lingsma HF; Steyerberg EW; Lesaffre E
    BMC Med Res Methodol; 2011 May; 11():77. PubMed ID: 21605357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials.
    Lu J; Marmarou A; Lapane KL;
    J Neurotrauma; 2012 Mar; 29(5):719-26. PubMed ID: 21815785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.